Introduction: What they say
A recent study from From the Department of Pharmacology, Second Military Medical University, Shanghai, China; Department of Science and Education, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China; and Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China (C.-Y.M.) shows that “Regenerative Neurogenesis After Ischemic Stroke Promoted by Nicotinamide Phosphoribosyltransferase-Nicotinamide Adenine Dinucleotide Cascade” This study was published in the June 9 2015 issue of the journal Stroke by Prof Miao CY, Zhao Y, and others.
What we say:
On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Molecular therapy for Stroke: Lithium, a mood stabilizing agent used in the treatment of Bipolar disorder, augments regenerative neurogenesis after Ischemic Stroke and ameliorates stroke damage and neurological deficits via up regulation of its target gene NAMPT.
From research findings to therapeutic opportunity:
Figure 1. Mechanistic insights into how Lithium promotes neural functional recovery after stroke. Lithium promotes post-ischemic regeneration via up regulation of its target genes Sirtuins and NAMPT
This study suggests that Lithium, by increasing the expression of of its target genes, it may: (1) increase the expression of NAMPT; (2) increase Sirtuins expression; (3) enhance neural stem cells; (4) promote neural functional recovery; (5) activate neuronal survival pathway; (6) promote post-ischemic regeneration after stroke; and (7) attenuate neurological deficits (Fig.1). [easy_payment currency=”USD”]
Together, this study suggests that pharmacological formulations encompassing “Lithium or its analogues either alone or in combination with other drugs” may be used to treat patients suffering from stroke and neurological deficits.
Details of the idea posted:
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Amount: $200#
Undisclosed mechanistic information: How Lithium increases the expression of NAMPT and promotes regenerative neurogenesis after ischemic Stroke
For purchase and payment details, you may reach us at info@genomediscovery.org
# Research cooperation
References:
Citation: Boominathan, L., Molecular therapy for Stroke: Lithium, a mood stabilizing agent used in the treatment of Bipolar disorder, augments regenerative neurogenesis after Ischemic Stroke and ameliorates stroke damage and neurological deficits via up regulation of its target gene NAMPT, 27/April/2017, 3.19 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
Web: http://genomediscovery.org or http://newbioideas.com